BerandaVBIVQ • OTCMKTS
add
VBI Vaccines Inc
Tutup sebelumnya
$0,00050
Rentang hari
$0,00050 - $0,00060
Rentang tahun
$0,00020 - $0,051
Kapitalisasi pasar
7,17Â rb USD
Volume Rata-Rata
56,23Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
OTCMKTS
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,21Â jt | 150,31% |
Biaya operasional | 10,24Â jt | -37,68% |
Laba bersih | -17,90Â jt | 35,50% |
Margin laba bersih | -1,47Â rb | 74,23% |
Penghasilan per saham | — | — |
EBITDA | -11,26Â jt | 40,75% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 12,60Â jt | -68,82% |
Total aset | 75,44Â jt | -41,27% |
Total liabilitas | 80,91Â jt | -3,03% |
Total ekuitas | -5,47 jt | — |
Saham yang beredar | 28,68 jt | — |
Harga terhadap nilai buku | -0,00 | — |
Tingkat pengembalian aset | -36,18% | — |
Tingkat pengembalian modal | -55,53% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -17,90Â jt | 35,50% |
Kas dari operasi | -11,77Â jt | 45,65% |
Kas dari investasi | -151,00Â rb | 71,72% |
Kas dari pembiayaan | 843,00 rb | — |
Perubahan kas bersih | -11,09Â jt | 50,13% |
Arus kas bebas | -4,40Â jt | 70,09% |
Tentang
Variation Biotechnologies Inc., also known as VBI Vaccines Inc., is a biopharmaceutical company, headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Ontario, Canada, and a research and manufacturing site in Rehovot, Israel. Its Ottawa facility has approximately thirty researchers working with National Research Council of Canada to produce a COVID-19 vaccine—VBI-2902. In August VBI received CA$56 million from the Government of Canada to prepare its vaccine for clinical trials by the end of 2020. The company's CEO, Jeff Baxter, said that VBI-2902 is cheaper to produce than other vaccines. Wikipedia
Didirikan
1965
Situs
Karyawan
135
